Cantor Fitzgerald Remains Sidelined on Allscripts (MDRX) Following Analyst Meeting
Tweet Send to a Friend
Cantor Fitzgerald reiterated a Neutral rating and $13.00 price target on Allscripts (NASDAQ: MDRX) following an analyst meeting. The company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
